Ki Tae Suk

8.3k total citations · 1 hit paper
208 papers, 5.0k citations indexed

About

Ki Tae Suk is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Ki Tae Suk has authored 208 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Epidemiology, 76 papers in Hepatology and 73 papers in Molecular Biology. Recurrent topics in Ki Tae Suk's work include Liver Disease Diagnosis and Treatment (126 papers), Liver Disease and Transplantation (53 papers) and Gut microbiota and health (51 papers). Ki Tae Suk is often cited by papers focused on Liver Disease Diagnosis and Treatment (126 papers), Liver Disease and Transplantation (53 papers) and Gut microbiota and health (51 papers). Ki Tae Suk collaborates with scholars based in South Korea, United States and Nigeria. Ki Tae Suk's co-authors include Dong Joon Kim, Soon Koo Baik, Haripriya Gupta, Moon Young Kim, Gwang Ho Baik, Chang Seok Bang, Sang Jun Yoon, Raja Ganesan, Sang Hak Han and Na Young Lee and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Ki Tae Suk

198 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation

2024 69 citations Haripriya Gupta, Jin‐Ju Jeong et al. Gut Microbes profile →

Peers

Countries citing papers authored by Ki Tae Suk

Since Specialization

Citations

This map shows the geographic impact of Ki Tae Suk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ki Tae Suk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ki Tae Suk more than expected).

Fields of papers citing papers by Ki Tae Suk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ki Tae Suk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ki Tae Suk. The network helps show where Ki Tae Suk may publish in the future.

Co-authorship network of co-authors of Ki Tae Suk

This figure shows the co-authorship network connecting the top 25 collaborators of Ki Tae Suk. A scholar is included among the top collaborators of Ki Tae Suk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ki Tae Suk. Ki Tae Suk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gut Microbiome-Based Strategies for the Control of Carbapenem-Resistant Enterobacteriaceae 2025 ·Journal of Microbiology and Biotechnology ·(unknown), Bong Soo Kim, Ki Tae Suk, Seung Soon Lee	1
2	Correspondence to editorial on: “Gut microbiome and metabolome signatures in liver cirrhosis-related complications” 2024 ·Clinical and Molecular Hepatology ·Satya Priya Sharma, Ki Tae Suk	0
3	Gut microbiota-based machine-learning signature for the diagnosis of alcohol-associated and metabolic dysfunction-associated steatotic liver disease 2024 ·Scientific Reports ·(unknown), Sang Jun Yoon, Sung‐Min Won, Ki‐Kwang Oh, (unknown), Ki Tae Suk, Unjoo Lee	16
4	Serum S100B Levels in Patients with Liver Cirrhosis and Hepatic Encephalopathy 2023 ·Diagnostics ·(unknown), Jung Hee Kim, Jang Han Jung, Sung Eun Kim, (unknown), Myoung-Kuk Jang, Sang Hoon Park, (unknown), Ki Tae Suk, Dong Joon Kim, Eun‐Kyoung Choi, Ji Won Park	1
5	Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics 2022 ·Biomedicines ·Ji Won Park, Jung Hee Kim, Sung Eun Kim, Jang Han Jung, Myoung-Kuk Jang, Sang Hoon Park, (unknown), (unknown), Ki Tae Suk, Dong Joon Kim	33
6	New insight into gut microbiota-derived metabolites to enhance liver regeneration via network pharmacology study 2022 ·Artificial Cells Nanomedicine and Biotechnology ·Ki‐Kwang Oh, Ickwon Choi, Haripriya Gupta, Raja Ganesan, Satya Priya Sharma, Sung‐Min Won, Jin‐Ju Jeong, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hee-Jin Park, Sang Jun Yoon, Mi‐Ran Choi, Dong Joon Kim, Ki Tae Suk	7
7	A Multicenter Retrospective Study on Clinical Characteristics and Outcome of Pyogenic Liver Abscess Focusing Multidrug-Resistant Organisms 2022 ·Journal of Clinical Medicine ·Ji Won Park, Jung Hee Kim, Jang Han Jung, Sung Eun Kim, (unknown), (unknown), Ki Tae Suk, Myoung-Kuk Jang, Dong Joon Kim, (unknown), Sang Hoon Park	5
8	Platelet-to-White Blood Cell Ratio: A Feasible Biomarker for Pyogenic Liver Abscess 2022 ·Diagnostics ·(unknown), Ji Won Park, Jung Hee Kim, Jang Han Jung, Hyoung Su Kim, Ki Tae Suk, Myoung-Kuk Jang, Sang Hoon Park, (unknown), Dong Joon Kim, Sung Eun Kim	11
9	The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure 2021 ·International Journal of Molecular Sciences ·Sung Eun Kim, Ji Won Park, (unknown), Myoung-Kuk Jang, Ki Tae Suk, Dong Joon Kim	12
10	Changing Trends in Liver Cirrhosis Etiology and Severity in Korea: the Increasing Impact of Alcohol 2021 ·Journal of Korean Medical Science ·(unknown), Chung Hwan Jun, Jeong Han Kim, Eileen L. Yoon, Byung Seok Kim, Jeong Eun Song, Ki Tae Suk, Moon Young Kim, Seong Hee Kang	11
11	LactobacillusandPediococcusameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome 2020 ·Gut Microbes ·Na Young Lee, Sang Jun Yoon, Dae Hee Han, Haripriya Gupta, Gi Soo Youn, Min Jea Shin, Young Lim Ham, (unknown), Byung‐Yong Kim, (unknown), Do Yup Lee, Tae‐Sik Park, (unknown), Byoung Kook Kim, (unknown), In Suk Choi, Ji Taek Hong, Dong Joon Kim, Sang Hak Han, Ki Tae Suk	95
12	Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study 2020 ·Cancers ·Ji Hyun Kim, Seong Hee Kang, Minjong Lee, Gi Soo Youn, Tae Suk Kim, Baek Gyu Jun, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Dong Joon Kim, Soon Koo Baik, Dae Hee Choi, Ki Tae Suk	9
13	Lactobacillus lactis CKDB001 ameliorate progression of nonalcoholic fatty liver disease through of gut microbiome: addendum 2020 ·Gut Microbes ·Na Young Lee, (unknown), Byoung Kook Kim, Byung‐Yong Kim, Tae‐Sik Park, Ki Tae Suk	11
14	Prognosis predictability of serum and urine renal markers in patients with decompensated cirrhosis: A multicentre prospective study 2020 ·Liver International ·Tae Hyung Kim, Yeon Seok Seo, Seong Hee Kang, Moon Young Kim, Sang Gyune Kim, Hyo Young Lee, Jeong‐Hoon Lee, Young‐Sun Lee, Ji Hoon Kim, Soung Won Jeong, Jae Young Jang, Ki Tae Suk, Young Kul Jung, Hyonggin An, Hyung Joon Yim, Young Seok Kim, Soon Ho Um, (unknown)	16
15	The New Cutoff Value of the Hepatic Venous Pressure Gradient on Predicting Long-Term Survival in Cirrhotic Patients 2019 ·Journal of Korean Medical Science ·Tae Yeob Kim, Ki Tae Suk, Soung Won Jeong, Tom Ryu, Dong Joon Kim, Soon Koo Baik, Joo Hyun Sohn, Woo Kyoung Jeong, Eun Hee Choi, Jae Young Jang, Moon Young Kim	4
16	Accumulation of citrullinated glial fibrillary acidic protein in a mouse model of bile duct ligation-induced hepatic fibrosis 2018 ·PLoS ONE ·Sung Eun Kim, Ji Won Park, (unknown), Byungki Jang, (unknown), Hee‐Jun Kim, Akihito Ishigami, Hyoung Su Kim, Ki Tae Suk, Dong Joon Kim, Choong Kee Park, Eun‐Kyoung Choi, Myoung-Kuk Jang	14
17	Prognostic Significance of the Hemodynamic and Clinical Staging in the Prediction of Mortality in Patients with Chronic Liver Disease 2014 ·Sang Hyun Park, Eun Jin Kim, Hyo Sun Kim, Chang Seok Bang, Ki Tae Suk, Dong Joon Kim, (unknown), Ji Won Park, Sung Eun Kim, Myoung Kuk Jang, Sang Hoon Park, (unknown), (unknown)	1
18	Effects of Probiotics (Cultured Lactobacillus Subtilis/Streptococcus Faecium) in the Treatment of Alcoholic Hepatitis 2014 ·Ki Tae Suk, Dong Joon Kim, Eun Jin Kim, (unknown), (unknown), (unknown), Soon Koo Baik, Young Don Kim, Gab Jin Cheon, Dae Hee Choi	1
19	Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction 2006 ·Gastrointestinal Endoscopy ·Ki Tae Suk, Hyun Soo Kim, Jae Woo Kim, Soon Koo Baik, Sang Ok Kwon, Ho Gak Kim, Don Haeng Lee, (unknown), Byung Moo Yoo, Jin Hong Kim, Young Soo Moon, Dong Ki Lee	115
20	문맥압 항진증을 동반한 간경변 환자에서 propranolol이 문맥압에 미치는 효과 2003 ·The Korean Journal of Internal Medicine ·Soon Koo Baik, (unknown), (unknown), (unknown), (unknown), Ki Tae Suk, (unknown), Hyun Soo Kim, Dong Ki Lee, Sang Ok Kwon, Young Jin Kim, Joong Wha Park, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact